Palvella Therapeutics PVLA
NASDAQ PVLA
$167.27 -1.44 (-0.86%)
As of: Nov 11, 2026 · 11:57 AM EST

Palvella Therapeutics (PVLA) Non Operating Interest Expenses (2014 - 2024)

Updated

Palvella Therapeutics' Non Operating Interest Expenses came in at $181,000 for Q4 2024, down 17.7% from the prior quarter.

Analysis

Palvella Therapeutics (PVLA) Non Operating Interest Expenses (2014 - 2024) Analysis & Trends

For FY2024, Palvella Therapeutics' Non Operating Interest Expenses was $430,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Palvella Therapeutics 2.47 Bn 2.23 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 181,000.00
Sep 30, 2024 220,000.00
Jun 30, 2024 29,000.00
Jun 30, 2015 53.00
Mar 31, 2015 4,170.00
Jun 30, 2014 113,793.00
Mar 31, 2014 109,289.00
API Access

Palvella Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=PVLA&period=max&api_key=YOUR_API_KEY